| 1. Smith BJ, McKimm-Breshkin JL, McDonald M, Fernley RT, Varghese JN, Colman PM.. (2002) Structural studies of the resistance of influenza virus neuramindase to inhibitors., 45 (11): [PMID:12014958] [10.1021/jm010528u] |
| 2. Babu YS, Chand P, Bantia S, Kotian P, Dehghani A, El-Kattan Y, Lin TH, Hutchison TL, Elliott AJ, Parker CD, Ananth SL, Horn LL, Laver GW, Montgomery JA.. (2000) BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design., 43 (19): [PMID:11000002] [10.1021/jm0002679] |
| 3. Chand P, Kotian PL, Dehghani A, El-Kattan Y, Lin TH, Hutchison TL, Babu YS, Bantia S, Elliott AJ, Montgomery JA.. (2001) Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity., 44 (25): [PMID:11728184] [10.1021/jm010277p] |
| 4. Lü WJ, Chen YL, Ma WP, Zhang XY, Luan F, Liu MC, Chen XG, Hu ZD.. (2008) QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network., 43 (3): [PMID:18255197] [10.1016/j.ejmech.2007.04.011] |
| 5. Prado-Prado FJ, Martinez de la Vega O, Uriarte E, Ubeira FM, Chou KC, González-Díaz H.. (2009) Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks., 17 (2): [PMID:19112024] [10.1016/j.bmc.2008.11.075] |
| 6. Chavas LM, Kato R, Suzuki N, von Itzstein M, Mann MC, Thomson RJ, Dyason JC, McKimm-Breschkin J, Fusi P, Tringali C, Venerando B, Tettamanti G, Monti E, Wakatsuki S.. (2010) Complexity in influenza virus targeted drug design: interaction with human sialidases., 53 (7): [PMID:20222714] [10.1021/jm100078r] |
| 7. Oakley AJ, Barrett S, Peat TS, Newman J, Streltsov VA, Waddington L, Saito T, Tashiro M, McKimm-Breschkin JL.. (2010) Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses., 53 (17): [PMID:20695427] [10.1021/jm100621s] |
| 8. Okomo-Adhiambo M, Demmler-Harrison GJ, Deyde VM, Sheu TG, Xu X, Klimov AI, Gubareva LV.. (2010) Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance., 54 (5): [PMID:20194700] [10.1128/aac.01608-09] |
| 9. Abed Y, Simon P, Boivin G.. (2010) Prophylactic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H274Y neuraminidase mutation., 54 (7): [PMID:20404128] [10.1128/aac.01681-09] |
| 10. Hurt AC, Holien JK, Barr IG.. (2009) In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses., 53 (10): [PMID:19651908] [10.1128/aac.00334-09] |
| 11. Nguyen HT, Sheu TG, Mishin VP, Klimov AI, Gubareva LV.. (2010) Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays., 54 (9): [PMID:20585136] [10.1128/aac.00581-10] |
| 12. Kohno S, Kida H, Mizuguchi M, Shimada J, S-021812 Clinical Study Group.. (2010) Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection., 54 (11): [PMID:20713668] [10.1128/aac.00474-10] |
| 13. Bromba CM, Mason JW, Brant MG, Chan T, Lunke MD, Petric M, Boulanger MJ, Wulff JE.. (2011) The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase., 21 (23): [PMID:22001088] [10.1016/j.bmcl.2011.09.076] |
| 14. Richards MR, Brant MG, Boulanger MJ, Cairo CW, Wulff JE. (2014) Conformational analysis of peramivir reveals critical differences between free and enzyme-bound states, 5 (10): [10.1039/C4MD00168K] |
| 15. Wang PC, Fang JM, Tsai KC, Wang SY, Huang WI, Tseng YC, Cheng YS, Cheng TJ, Wong CH.. (2016) Peramivir Phosphonate Derivatives as Influenza Neuraminidase Inhibitors., 59 (11): [PMID:27167096] [10.1021/acs.jmedchem.6b00029] |
| 16. Wang Z, Cheng LP, Zhang XH, Pang W, Li L, Zhao JL.. (2017) Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors., 27 (24): [PMID:29141777] [10.1016/j.bmcl.2017.11.003] |
| 17. Wang PC, Chiu DC, Jan JT, Huang WI, Tseng YC, Li TT, Cheng TJ, Tsai KC, Fang JM.. (2018) Peramivir conjugates as orally available agents against influenza H275Y mutant., 145 [PMID:29324342] [10.1016/j.ejmech.2017.12.072] |
| 18. Richards MR, Guo T, Hunter CD, Cairo CW.. (2018) Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity., 26 (19): [PMID:29903413] [10.1016/j.bmc.2018.05.035] |
| 19. WHO Anatomical Therapeutic Chemical Classification, |
| 20. Unpublished dataset, |
| 21. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
| 22. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson. (2020) Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2, [10.1101/2020.04.21.054387] |
| 23. Wang J, Chen F, Liu Y, Liu Y, Li K, Yang X, Liu S, Zhou X, Yang J.. (2018) Spirostaphylotrichin X from a Marine-Derived Fungus as an Anti-influenza Agent Targeting RNA Polymerase PB2., 81 (12): [PMID:30516983] [10.1021/acs.jnatprod.8b00656] |
| 24. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 25. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 26. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 27. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 28. Liao Y,Ye Y,Li S,Zhuang Y,Chen L,Chen J,Cui Z,Huo L,Liu S,Song G. (2020) Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PA endonuclease., 189 [PMID:31954881] [10.1016/j.ejmech.2020.112048] |
| 29. Zhang H,Wang K,Zhu H,Zhao X,Zhao H,Lei Z,Chen B,Yang F,Liu K,Zhang K,Wang J,Tian Y. (2020) Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor., 200 [PMID:32512482] [10.1016/j.ejmech.2020.112423] |
| 30. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
| 31. Lv X, Wang P, Li C, Cheng S, Bi Y, Li X.. (2021) Zanamivir-Cholesterol Conjugate: A Long-Acting Neuraminidase Inhibitor with Potent Efficacy against Drug-Resistant Influenza Viruses., 64 (23.0): [PMID:34797984] [10.1021/acs.jmedchem.1c01531] |
| 32. Keil JM, Rafn GR, Turan IM, Aljohani MA, Sahebjam-Atabaki R, Sun XL.. (2022) Sialidase Inhibitors with Different Mechanisms., 65 (20.0): [PMID:36252951] [10.1021/acs.jmedchem.2c01258] |
| 33. Liu Z, Gu S, Zhu X, Liu M, Cao Z, Qiu P, Li S, Liu S, Song G.. (2022) Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors., 227 [PMID:34700269] [10.1016/j.ejmech.2021.113929] |
| 34. Bourguet E, Figurska S, Fra Czek MM.. (2022) Human Neuraminidases: Structures and Stereoselective Inhibitors., 65 (4.0): [PMID:35170942] [10.1021/acs.jmedchem.1c01612] |
